B Gazzard

发表

What we know so far.

B. Gazzard, B Gazzard, 1996, AIDS.

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

B. Gazzard, C. Katlama, K. Ruxrungtham, 2004, The Lancet.

A comparison of computational models with and without genotyping for prediction of response to second‐line HIV therapy

B Gazzard, D Wang, P Reiss, 2014, HIV medicine.

Changes in sleep quality and brain wave patterns following initiation of an efavirenz‐containing triple antiretroviral regimen

B. Gazzard, C. Fletcher, G. Moyle, 2006, HIV medicine.